risankizumab,mirikizumab,ustekinumab
janssen,abbvie,eli lilly
['ulcerative colitis', 'lucent-2', ' uste ', 'mirikizumab', 'ibd', 'risan']
g.d haens presenting the data of the lucent-2 maintenance therapy with mirikizumab in ulcerative colitis. super interesting the carry over effect also observed in uste and risankizumab trials after having responded to induction #uegweek #uegweek22 #ibd 
Celebrate life. Gastroenterologist. IBD. WGH Edinburgh/Zaragoza-Spain.I share my slides in @ibdeii